Health
Metformin drug decreases mortality rate in COVID-19 patients with type 2 diabetes – News-Medical.Net
Use of the diabetes drug metformin — before a diagnosis of COVID-19 — is associated with a threefold decrease in mortality in COVID-19 patients with Type 2 diabetes,…
Use of the diabetes drug metformin — before a diagnosis of COVID-19 — is associated with a threefold decrease in mortality in COVID-19 patients with Type 2 diabetes, according to a racially diverse study at the University of Alabama at Birmingham. Diabetes is a significant comorbidity for COVID-19.
This beneficial effect remained, even after correcting for age, sex, race, obesity, and hypertension or chronic kidney disease and heart failure.”
Anath Shalev, M.D, Study Lead Author and Director of…
-
Noosa News23 hours agoWorking for someone else made it hard to care for my daughter. So I quit
-
General24 hours agoReflections from a broken Europe
-
Business9 hours agoFord CEO makes stunning prediction about artificial intelligence
-
General19 hours ago‘Potential’ hacker contacts Qantas over data breach